Structure and Governance

Audit Committee Board of Directors CQDM (Management) Executive Committee Corporate Governance and Nominating Committee Strategic Orientation Committee Explore Advisory Committee

Board of Directors

Chairman

Richard Fajzel
Vice President, Business Development, Exactis Innovation

Members

Jennifer Chan
Vice President, Policy and Communications, Merck Canada

Max Fehlmann
President and Chief Executive Officer, Neomed Institute

Michel Goldman
Director, Institute for Interdisciplinary Innovation in Healthcare, Université Libre de Bruxelles

Diane Gosselin
President and Chief Executive Officer, CQDM

Raphael Hofstein
President and Chief Executive Officer, MaRS Innovation

Vassilios Papadopoulos
Director, Research Institute of the McGill University Health Center (RI-MUHC)

Ken Pastor
General Partner, CTI Capital

Louise Proulx 
Chief Development Officer, Therillia Development Company

Uwe Schoenbeck
Chief Scientific Officer, External Research & Development Innovation (ERDI), Pfizer

Marc Zarenda
Scientific Director, AstraZeneca Canada

Honorary Members

John Helou
President, Pfizer Canada

Remi Quirion
Chief Scientist, Fonds de recherche du Québec

Observers

Martin Houle
Director, Industrial Partnerships, Quebec Ministry of Economy, Innovation and Exports (MEIE)

Réginald Thériault
Program Deputy Director, Networks of Centres of Excellence

Secretary

François Painchaud 
Lawyer, Partner, ROBIC, LLP


Executive Committee

Chairman

Richard Fajzel
Vice President, Business Development, Exactis Innovation

Members

Jennifer Chan
Vice President, Policy and Communications, Merck Canada

Diane Gosselin
President and Chief Executive Officer, CQDM

Vassilios Papadopoulos
Director, Research Institute of the McGill University Health Center (RI-MUHC)


Audit Committee

Chairman

Ken Pastor
General Partner, CTI Capital

Member

Domenic DeLuca, Gladius Pharmaceuticals


Corporate Governance and Nominating Committee

Chairman

Richard Fajzel
Vice President, Business Development, Exactis Innovation

Members

Jennifer Chan
Vice President, Policy and Communications, Merck Canada

Michel Goldman
Director, Institute for Interdisciplinary Innovation in Healthcare, Université Libre de Bruxelles

Diane Gosselin
President and Chief Executive Officer, CQDM

Raphael Hofstein
President and Chief Executive Officer, MaRS Innovation


Strategic Orientation Committee

Chairman

Steven Xanthoudakis
Director, Business Development & Licensing, Merck Canada

Members

André Darveau
Dean, Faculty of Sciences and Engineering, Université Laval

Peter Doig
Associate Director, Innovative Medicines - Discovery Sciences, AstraZeneca R&D UK

H. Christian Fibiger
Assistant Dean, Research, Faculty of Medicine, University of British Columbia

Diane Gosselin
President and Chief Executive Officer, CQDM

Daniel Hétu
Managing Director, Lumira Capital

Mark Lim 
Program Officer, Diagnostics, Integrated Development and Global Health, Gates Foundation

Patrice Roy
Regional Director, Medical Affairs, Pfizer Canada

Observers

Catherine Richard
Advisor, Industrial Partnerships, Quebec Ministry of Economy, Innovation and Exports (MEIE)

Réginald Thériault
Program Deputy Director, Networks of Centres of Excellence


Explore Advisory Committee

Chairman

Patrice Roy
Regional Director, Medical Affairs, Pfizer Canada

Members

Luc Boulay
Senior Clinical Research Scientist, Neuroscience, Eli Lilly Canada

Anders Brunmark
Director, External Innovation, Discovery Sciences, Janssen R&D

Peter Doig
Associate Director, Innovative Medicines - Discovery Sciences, AstraZeneca R&D UK

Michael Draper
Senior Director, Scouting and Partnering, Sanofi R&D

Jean Godin
Vice President, Scientific Affairs, Novartis Canada

Diane Gosselin
President and CEO, CQDM

Cyrille Kuhn
Executive Director, Research Networking & Strategic Planning, Boehringer Ingelheim Pharmaceuticals, USA

Amyn Sayani
Director, R&D Alliances, GSK Canada

Steven Xanthoudakis
Director, Business Development & Licensing, Merck Canada